SPDR S&P Pharmaceuticals ETF Rating $43.27 +0.52 (+1.22%) (As of 07/26/2024 ET) Add Compare Share Share RatingsStock AnalysisChartDividendHeadlinesHoldingsOwnershipRatingsStock AnalysisChartDividendHeadlinesHoldingsOwnershipRatings SPDR S&P Pharmaceuticals ETF Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.XPH Aggregate RatingModerate Buy2.72Holdings in XPH have an aggregate rating of Moderate Buy based on 315 analyst ratings issued in the past year covering 43 companies (99.9% of the portfolio).XPH Aggregate Price Target$64.8749.91% UpsideHigh Prediction$82.08Average Prediction$64.87Low Prediction$48.00Holdings in XPH have an aggregate price target of $64.87 and a range of $48.00 to $82.08 covering 43 companies (99.9% of the portfolio).XPH Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy19 Buy rating(s)Moderate Buy17 Moderate Buy rating(s)Hold7 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by SPDR S&P Pharmaceuticals ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 43 XPH Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings4.24%ITCIIntra-Cellular Therapies$80.39-0.6%4.6784 of 5 stars4.68 / 5 stars2.83$94.83 18.0%12Short Interest ↓News Coverage4.22%AXSMAxsome Therapeutics$86.53+0.6%4.685 of 5 stars4.69 / 5 stars2.93$123.85 43.1%14Analyst ForecastAnalyst RevisionNews Coverage4.09%VTRSViatris$12.08+2.7%1.5242 of 5 stars1.52 / 5 stars2.00$12.33 2.1%3Short Interest ↓News Coverage3.92%PFEPfizer$30.77+3.4%4.7934 of 5 stars4.79 / 5 stars2.38$34.50 12.1%13Upcoming EarningsOptions VolumeNews Coverage3.92%ZTSZoetis$179.84-0.5%4.6122 of 5 stars4.61 / 5 stars3.00$212.67 18.3%8Analyst ForecastShort Interest ↓3.92%LLYEli Lilly and Company$805.12-2.0%4.64 of 5 stars4.64 / 5 stars2.84$858.72 6.7%19Analyst Forecast3.88%ARVNArvinas$29.65+0.4%1.3614 of 5 stars1.36 / 5 stars2.88$61.13 106.2%16Short Interest ↑Gap Up3.81%CTLTCatalent$58.68+0.4%1.9706 of 5 stars1.97 / 5 stars2.18$55.65 -5.2%11Analyst ForecastShort Interest ↑3.79%JNJJohnson & Johnson$160.68+0.7%4.7799 of 5 stars4.78 / 5 stars2.43$173.00 7.7%14Analyst DowngradeShort Interest ↓3.76%RPRXRoyalty Pharma$28.79+0.4%4.8971 of 5 stars4.90 / 5 stars2.80$41.80 45.2%5Positive News3.73%OGNOrganon & Co.$22.21+0.6%4.1099 of 5 stars4.11 / 5 stars2.50$22.60 1.8%4News Coverage3.69%PRGOPerrigo$28.11+0.1%4.9675 of 5 stars4.97 / 5 stars3.00$39.33 39.9%3Upcoming EarningsAnalyst DowngradeNews Coverage3.66%BMYBristol-Myers Squibb$50.40+11.3%4.4835 of 5 stars4.48 / 5 stars2.12$57.73 14.6%17Earnings ReportAnalyst ForecastAnalyst RevisionNews CoverageGap UpHigh Trading Volume3.54%MRKMerck & Co., Inc.$125.30-0.4%4.3886 of 5 stars4.39 / 5 stars2.75$135.36 8.0%12Upcoming EarningsDividend Announcement3.46%CORTCorcept Therapeutics$35.60+2.1%4.7934 of 5 stars4.79 / 5 stars3.00$45.10 26.7%4Upcoming EarningsPositive News3.44%JAZZJazz Pharmaceuticals$111.57+1.9%4.9628 of 5 stars4.96 / 5 stars2.80$185.86 66.6%15Upcoming Earnings2.72%OCULOcular Therapeutix$8.43+1.8%3.9595 of 5 stars3.96 / 5 stars2.83$15.83 87.8%62.69%ELANElanco Animal Health$12.89+0.5%3.8689 of 5 stars3.87 / 5 stars2.57$17.57 36.3%7Short Interest ↑2.39%PBHPrestige Consumer Healthcare$70.68+0.4%4.4951 of 5 stars4.50 / 5 stars2.75$98.25 39.0%4Positive News2.07%LBPHLongboard Pharmaceuticals$37.40+4.4%2.8205 of 5 stars2.82 / 5 stars3.00$54.63 46.1%8Upcoming Earnings2.07%AMPHAmphastar Pharmaceuticals$42.48+0.8%4.8599 of 5 stars4.86 / 5 stars2.50$64.67 52.2%4Positive News2.00%SUPNSupernus Pharmaceuticals$30.75+0.2%3.9234 of 5 stars3.92 / 5 stars3.00$41.00 33.3%11.93%TARSTarsus Pharmaceuticals$25.01-11.4%1.6052 of 5 stars1.61 / 5 stars2.86$50.83 103.3%7News CoverageHigh Trading Volume1.87%LGNDLigand Pharmaceuticals$107.14+1.1%4.4445 of 5 stars4.44 / 5 stars3.00$126.33 17.9%3Short Interest ↑1.83%COLLCollegium Pharmaceutical$36.08+1.9%3.3895 of 5 stars3.39 / 5 stars2.40$40.75 12.9%5Upcoming EarningsNews Coverage1.79%EWTXEdgewise Therapeutics$18.98+1.3%1.4687 of 5 stars1.47 / 5 stars3.00$33.20 74.9%5Analyst ForecastNews Coverage1.68%HRMYHarmony Biosciences$33.92+1.9%3.6838 of 5 stars3.68 / 5 stars2.56$41.67 22.8%9Analyst RevisionNews Coverage1.44%PCRXPacira BioSciences$20.03+0.3%4.943 of 5 stars4.94 / 5 stars2.90$43.60 117.7%10Upcoming EarningsAnalyst Forecast1.38%ANIPANI Pharmaceuticals$63.25+2.0%4.8062 of 5 stars4.81 / 5 stars3.00$82.75 30.8%4Short Interest ↑1.38%SAVACassava Sciences$14.92+17.0%3.3117 of 5 stars3.31 / 5 stars2.00$131.00 778.0%1Upcoming EarningsShort Interest ↑1.38%LQDALiquidia$11.63+1.5%2.2785 of 5 stars2.28 / 5 stars2.50$21.60 85.7%61.33%MNMDMind Medicine (MindMed)$9.40-0.3%2.591 of 5 stars2.59 / 5 stars3.18$22.00 134.2%11Upcoming EarningsAnalyst ForecastShort Interest ↑Analyst RevisionNews CoverageGap Up1.21%INVAInnoviva$18.55+2.0%0.9543 of 5 stars0.95 / 5 stars3.001Analyst DowngradeNews Coverage1.19%AMRXAmneal Pharmaceuticals$7.44+0.8%1.2795 of 5 stars1.28 / 5 stars3.00$8.25 10.9%41.06%EOLSEvolus$12.31+1.5%3.8447 of 5 stars3.84 / 5 stars3.00$21.67 76.0%4Upcoming EarningsShort Interest ↑News Coverage1.01%EYPTEyePoint Pharmaceuticals$9.71+2.6%2.9967 of 5 stars3.00 / 5 stars3.00$33.29 242.8%7Gap Up0.88%HROWHarrow$24.44+0.9%1.2696 of 5 stars1.27 / 5 stars3.00$29.60 21.1%3Positive News0.73%ELVNEnliven Therapeutics$27.31+9.2%1.6524 of 5 stars1.65 / 5 stars3.33$33.00 20.8%3Short Interest ↓Gap Up0.72%PLRXPliant Therapeutics$13.37+0.5%4.288 of 5 stars4.29 / 5 stars3.00$45.38 239.4%9News Coverage0.68%FULCFulcrum Therapeutics$8.88+2.8%1.5654 of 5 stars1.57 / 5 stars3.00$15.57 75.4%7Upcoming EarningsShort Interest ↑News CoverageGap Up0.50%NUVBNuvation Bio$3.73+1.1%2.684 of 5 stars2.68 / 5 stars3.00$6.60 76.9%5Upcoming EarningsGap Up0.46%XERSXeris Biopharma$2.61+2.0%3.7176 of 5 stars3.72 / 5 stars3.00$4.63 77.2%4Positive News0.44%WVEWave Life Sciences$6.53+3.7%4.4484 of 5 stars4.45 / 5 stars2.86$13.17 101.6%7Upcoming EarningsShort Interest ↓News CoverageGap Up This page (NYSEARCA:XPH) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredNext opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has...Crypto 101 Media | SponsoredGet out of cash before the Fed's next meeting"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | SponsoredGrab a pen and write down this ticker - here's whyA megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredThe #1 Crypto for 2024 (3 Cent Coin)Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsoredtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligen...Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SPDR S&P Pharmaceuticals ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share SPDR S&P Pharmaceuticals ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free XPH Stock Alerts